title: Vibrio parahaemolyticus inhibition of Rho family GTPase activation requires a functional chromosome I type III secretion system.
abstract: Vibrio parahaemolyticus is a leading cause of seafood-borne gastroenteritis; however, its virulence mechanisms are not well understood. The identification of type III secreted proteins has provided candidate virulence factors whose functions are still being elucidated. Genotypic strain variability contributes a level of complexity to understanding the role of different virulence factors. The ability of V. parahaemolyticus to inhibit Rho family GTPases and cause cytoskeletal disruption was examined with HeLa cells. After HeLa cells were infected, intracellular Rho activation was inhibited in response to external stimuli. In vitro activation of Rho, Rac, and Cdc42 isolated from infected HeLa cell lysates was also inhibited, indicating that the bacteria were specifically targeting GTPase activation. The inhibition of Rho family GTPase activation was retained for clinical and environmental isolates of V. parahaemolyticus and was dependent on a functional chromosome I type III secretion system (CI-T3SS). GTPase inhibition was independent of hemolytic toxin genotype and the chromasome II (CII)-T3SS. Rho inhibition was accompanied by a shift in the total actin pool to its monomeric form. These phenotypes were abrogated in a mutant strain lacking the CI-T3S effector Vp1686, suggesting that the inhibiting actin polymerization may be a downstream effect of Vp1686-dependent GTPase inhibition. Although Vp1686 has been previously characterized as a potential virulence factor in macrophages, our findings reveal an effect on cultured HeLa cells. The ability to inhibit Rho family GTPases independently of the CII-T3SS and the hemolytic toxins may provide insight into the mechanisms of virulence used by strains lacking these virulence factors.
authors.affiliation: Department of Microbiology and Infectious Diseases, University of Calgary, 3330 Hospital Dr. NW, Calgary, AB T2N 4N1, Canada.
authors.forename: Timothy
authors.initials: T
authors.lastname: Casselli
authors.forename: Tarah
authors.initials: T
authors.lastname: Lynch
authors.forename: Carolyn M
authors.initials: CM
authors.lastname: Southward
authors.forename: Bryan W
authors.initials: BW
authors.lastname: Jones
authors.forename: Rebekah
authors.initials: R
authors.lastname: DeVinney
mesh_terms: D000199:Actins / Q000378:metabolism; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism*; D002352:Carrier Proteins / Q000235:genetics / Q000378:metabolism*; D002876:Chromosomes, Bacterial; D004847:Epithelial Cells / Q000382:microbiology; D017353:Gene Deletion; D006367:HeLa Cells; D006460:Hemolysin Proteins / Q000235:genetics; D006801:Humans; D014736:Vibrio parahaemolyticus / Q000235:genetics / Q000502:physiology*; D037521:Virulence Factors / Q000235:genetics / Q000378:metabolism*; D020764:cdc42 GTP-Binding Protein / Q000037:antagonists & inhibitors / Q000302:isolation & purification; D020744:rac GTP-Binding Proteins / Q000037:antagonists & inhibitors / Q000302:isolation & purification; D020741:rho GTP-Binding Proteins / Q000037:antagonists & inhibitors* / Q000302:isolation & purification
chemical_list: D000199:Actins; D001426:Bacterial Proteins; D002352:Carrier Proteins; D006460:Hemolysin Proteins; D037521:Virulence Factors; C073845:hemolysin, Vibrio; D020764:cdc42 GTP-Binding Protein; D020744:rac GTP-Binding Proteins; D020741:rho GTP-Binding Proteins